Purchase Order 75F40125P00012
Award Date
12/10/24
Potential Completion Date
5/2/25
Potential Value
$24K
Federal Agency
Food and Drug Administration
Awardee
University Of Florida
Ultimate Awardee
Not listed
NAICS Category
611430 - Professional and Management Development Training
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Available for Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Gainesville, FL 32611, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The University of Florida's Division of Sponsored Research was awarded a firm fixed price, definite contract valued at one million five hundred forty-three thousand one hundred fifty-three dollars and eighty cents ($1,543,153.80) by the Department of Health and Human Services' Food and Drug Administration. The contract has no set-aside designation. It will support a pharmacokinetics study with performance taking place in Gainesville, Florida through April 2020. As a leading public research...
The U.S. Food and Drug Administration (FDA) awarded a $296,477.00 definitive contract to the University of Florida (UF) Division of Sponsored Research for research related to "REAL-TIME RISK STRATIFICATION FOR HYPO- OR HYPERGLYCEMIA TO ENHANCE GLUCOSE MANAGEMENT OUTCOMES IN HOSPITALS." The contract, which is not set-aside, has a completion date of September 29, 2017. UF, a major research institution, has an extensive portfolio of federal contract and grant awards across various...
This is a $749,980 firm fixed price contract awarded by the Food and Drug Administration (FDA) to the University of Florida (UF) to develop a "TERATOGENIC RISK IMPACT AND MITIGATION (TRIM): AN EVIDENCE-BASED DECISION FRAMEWORK". The contract has no set-aside designation. UF, through its Division of Sponsored Research, will lead the effort which includes clinical expertise from a subcontractor, The Johns Hopkins University. This contract was awarded under the FDA's Broad Agency...
The Department of Health and Human Services Food and Drug Administration awarded a $921,732.78 firm fixed-price definitive contract to the University of Florida's Division of Sponsored Research to conduct research on the "Systematic Evaluation of the Ex-Throat Plume Properties of MDI Formulations." The contract does not have any set-aside designation. As a public land-grant research university, the University of Florida has extensive experience providing research, development, testing,...
The Department of Health and Human Services Food and Drug Administration awarded a firm fixed-price purchase order to The Regents of the University of California, San Francisco (UCSF) for the Center for Drug Evaluation and Research (CDER) - Office of Executive Programs (OEP) Division of Learning and Organizational Development (DLOD) Drug Development and Regulatory Sciences Course. The $175,000.00 contract has a completion date of December 31, 2022. UCSF, a U.S. state government and educational...
The Department of Health and Human Services Food and Drug Administration (HHS FDA) awarded a $35,751.68 firm-fixed-price purchase order to Team Results USA LLC. This purchase order is for a one-year masterclass team simulation to be delivered in Silver Spring, Maryland from September 2023 through September 2024. As the regulatory agency responsible for protecting public health through ensuring the safety and effectiveness of human and veterinary drugs, medical devices, and other products, this...
The U.S. Food and Drug Administration (FDA) awarded a $400,000.00 firm-fixed price contract to the Regents of the University of Michigan, Office of Research and Sponsored Projects (University of Michigan) to advance the science of in vitro, animal model, pharmacokinetic studies, and/or real-world evidence studies to facilitate drug development, including studies focused on antimicrobial resistance and drug development. This contract has a period of performance through March 31, 2026. The...
The Regents of the University of California, doing business as the University of California San Francisco Controller's Office, was awarded a $564,554 firm fixed price purchase order by the United States Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research Office of Executive Programs Division of Learning and Organizational Development. Under this contract, the University of California San Francisco will provide Drug Development and...
The U.S. Food and Drug Administration (FDA) awarded a $696,359 firm-fixed-price contract to Duke University's Office of Research Administration Division to conduct research and development activities in support of regulatory science and innovation. The contract, which does not have a set-aside designation, originated from a Broad Agency Announcement (BAA) that solicits advanced proposals across nine key areas to advance scientific knowledge in support of the FDA's mission to protect public...
The University of Florida (UF) Division of Sponsored Research was awarded a Firm Fixed Price Delivery Order contract from the Office of Acquisitions and Grants, a civilian federal agency, with a ceiling value of $1,624. The contract, which does not have a set-aside designation, is for Task Order 8 under a larger Indefinite Delivery Contract (IDC) with the National Institute of Allergy and Infectious Diseases (NIAID). This IDC, valued at $146.3 million over 7 years, supports the development and...